27 years of historical data (1998–2024) · Healthcare · Medical - Diagnostics & Research
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
ICON Public Limited Company trades at 13.0x earnings, 75% below its 5-year average of 52.2x, sitting at the 22nd percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a discount of 41%. On a free-cash-flow basis, the stock trades at 8.5x P/FCF, 66% below the 5-year average of 24.9x.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9.5B | $17.4B | $23.4B | $16.0B | $21.1B | $10.4B | $9.4B | $7.1B | $6.2B | $4.2B | $4.7B |
| Enterprise Value | $12.5B | $20.5B | $27.0B | $20.6B | $26.0B | $10.0B | $9.3B | $7.0B | $6.2B | $4.4B | $4.9B |
| P/E Ratio → | 13.03 | 22.01 | 38.25 | 31.69 | 137.64 | 31.25 | 25.37 | 21.90 | 21.86 | 16.17 | 19.57 |
| P/S Ratio | 1.14 | 2.10 | 2.88 | 2.07 | 3.85 | 3.71 | 3.34 | 2.72 | 3.50 | 2.55 | 2.97 |
| P/B Ratio | 1.08 | 1.83 | 2.53 | 1.89 | 2.61 | 5.62 | 5.78 | 5.22 | 5.00 | 4.49 | 6.13 |
| P/FCF | 8.47 | 15.57 | 22.95 | 38.04 | 28.67 | 19.11 | 25.86 | 32.80 | 126.32 | 19.58 | 20.39 |
| P/OCF | 7.37 | 13.53 | 20.17 | 28.44 | 25.42 | 17.47 | 22.68 | 26.79 | 126.25 | 16.36 | 16.76 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
ICON Public Limited Company's enterprise value stands at 7.9x EBITDA, 61% below its 5-year average of 20.1x. The Healthcare sector median is 14.1x, placing the stock at a 44% discount on an enterprise-value basis.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.47 | 3.32 | 2.66 | 4.74 | 3.57 | 3.31 | 2.71 | 3.54 | 2.64 | 3.13 |
| EV / EBITDA | 7.91 | 12.91 | 17.49 | 14.58 | 35.15 | 20.54 | 17.69 | 16.00 | 15.57 | 11.85 | 14.54 |
| EV / EBIT | 11.43 | 19.04 | 28.84 | 25.78 | 68.52 | 25.32 | 21.11 | 18.58 | 18.26 | 13.75 | 17.51 |
| EV / FCF | — | 18.31 | 26.44 | 48.82 | 35.32 | 18.36 | 25.68 | 32.59 | 127.68 | 20.30 | 21.46 |
Margins and return-on-capital ratios measuring operating efficiency
ICON Public Limited Company earns an operating margin of 13.3%. Operating margins have expanded from 10.3% to 13.3% over the past 3 years, signaling improving operational efficiency. ROE of 8.4% is modest. ROIC of 6.5% represents adequate returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 29.4% | 29.4% | 29.6% | 28.6% | 27.5% | 28.9% | 29.6% | 29.6% | 41.3% | 42.3% | 42.3% |
| Operating Margin | 13.3% | 13.3% | 11.8% | 10.3% | 6.9% | 14.0% | 15.4% | 14.4% | 19.2% | 18.7% | 17.9% |
| Net Profit Margin | 9.6% | 9.6% | 7.5% | 6.5% | 2.8% | 11.7% | 13.3% | 12.4% | 16.0% | 15.7% | 15.2% |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 8.4% | 8.4% | 6.9% | 6.1% | 3.1% | 18.9% | 25.2% | 25.0% | 25.9% | 30.7% | 27.9% |
| ROA | 4.7% | 4.7% | 3.6% | 2.9% | 1.5% | 10.3% | 14.2% | 14.2% | 14.0% | 14.8% | 14.8% |
| ROIC | 6.5% | 6.5% | 5.6% | 4.6% | 3.9% | 19.6% | 22.7% | 21.5% | 21.2% | 22.1% | 22.9% |
| ROCE | 7.8% | 7.8% | 6.7% | 5.4% | 4.4% | 19.2% | 24.6% | 22.2% | 22.9% | 25.2% | 26.4% |
Solvency and debt-coverage ratios — lower is generally safer
ICON Public Limited Company carries a Debt/EBITDA ratio of 2.3x, which is manageable (30% below the sector average of 3.3x). Net debt stands at $3.1B ($3.6B total debt minus $539M cash). Interest coverage of 4.5x is adequate, though a cyclical earnings downturn could tighten the margin of safety.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.38 | 0.38 | 0.43 | 0.57 | 0.70 | 0.23 | 0.28 | 0.26 | 0.28 | 0.37 | 0.46 |
| Debt / EBITDA | 2.27 | 2.27 | 2.55 | 3.43 | 7.64 | 0.89 | 0.87 | 0.80 | 0.87 | 0.94 | 1.03 |
| Net Debt / Equity | — | 0.32 | 0.39 | 0.53 | 0.61 | -0.22 | -0.04 | -0.03 | 0.05 | 0.17 | 0.32 |
| Net Debt / EBITDA | 1.93 | 1.93 | 2.31 | 3.22 | 6.62 | -0.84 | -0.13 | -0.11 | 0.17 | 0.42 | 0.73 |
| Debt / FCF | — | 2.74 | 3.49 | 10.78 | 6.65 | -0.75 | -0.18 | -0.22 | 1.36 | 0.72 | 1.07 |
| Interest Coverage | 4.53 | 4.53 | 2.78 | 3.47 | 2.08 | 30.28 | 33.16 | 28.00 | 26.98 | 24.59 | 70.53 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.26x means ICON Public Limited Company can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has improved from 1.20x to 1.26x over the past 3 years.
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.26 | 1.26 | 1.21 | 1.20 | 1.19 | 1.87 | 1.44 | 2.18 | 1.95 | 1.94 | 1.51 |
| Quick Ratio | 1.26 | 1.26 | 1.21 | 1.20 | 1.19 | 1.87 | 1.43 | 2.17 | 1.94 | 1.93 | 1.51 |
| Cash Ratio | 0.19 | 0.19 | 0.13 | 0.11 | 0.30 | 0.75 | 0.50 | 0.75 | 0.64 | 0.53 | 0.33 |
| Asset Turnover | — | 0.49 | 0.48 | 0.45 | 0.32 | 0.81 | 0.97 | 1.10 | 0.80 | 0.91 | 0.92 |
| Inventory Turnover | — | — | — | 782.54 | — | — | 616.92 | 794.04 | 468.85 | 400.56 | 504.99 |
| Days Sales Outstanding | — | 125.66 | 130.32 | 132.09 | 138.05 | 157.55 | 131.85 | 117.78 | 146.58 | 145.04 | 147.56 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
ICON Public Limited Company returns 5.3% to shareholders annually primarily through share buybacks. The earnings yield of 7.7% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 7.7% | 4.5% | 2.6% | 3.2% | 0.7% | 3.2% | 3.9% | 4.6% | 4.6% | 6.2% | 5.1% |
| FCF Yield | 11.8% | 6.4% | 4.4% | 2.6% | 3.5% | 5.2% | 3.9% | 3.0% | 0.8% | 5.1% | 4.9% |
| Buyback Yield | 5.3% | 2.9% | 0.0% | 0.6% | 0.0% | 1.7% | 1.6% | 1.8% | 2.2% | 2.6% | 9.8% |
| Total Shareholder Yield | 5.3% | 2.9% | 0.0% | 0.6% | 0.0% | 1.7% | 1.6% | 1.8% | 2.2% | 2.6% | 9.8% |
| Shares Outstanding | — | $83M | $83M | $82M | $68M | $53M | $54M | $55M | $55M | $56M | $60M |
Compare ICLR with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $9B | 13.0 | 7.9 | 8.5 | 29.4% | 13.3% | 8.4% | 6.5% | 2.3 | |
| $9B | -62.5 | 13.0 | 17.3 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 | |
| $30B | 22.5 | 12.9 | 14.6 | 26.3% | 14.0% | 21.4% | 8.7% | 4.7 | |
| $12B | 27.9 | 21.2 | 17.9 | 30.1% | 21.1% | 70.2% | 154.9% | 0.4 | |
| $1B | 24.8 | 19.5 | — | 39.4% | 6.6% | 4.0% | 3.2% | 5.1 | |
| $21B | 24.6 | 12.7 | 17.5 | 26.8% | 10.9% | 10.5% | 7.8% | 3.3 | |
| $21B | 21.6 | 12.6 | 15.4 | 31.9% | 14.5% | 14.0% | 8.8% | 3.2 | |
| $2B | -13.5 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — | |
| $7B | 52.7 | 44.5 | 93.8 | 59.3% | 5.2% | 25.2% | 10.7% | 6.4 | |
| $176B | 26.7 | 19.0 | 27.9 | 37.7% | 18.2% | 13.1% | 7.5% | 3.8 | |
| $124B | 34.7 | 18.1 | 23.5 | 60.9% | 20.9% | 7.1% | 5.9% | 2.4 | |
| Healthcare Median | — | 22.1 | 14.1 | 18.7 | 63.9% | -5.3% | -33.7% | -10.8% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 27 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side business, growth, and profitability comparison vs Charles River Laboratories International, Inc..
Start ComparisonQuick answers to the most common questions about buying ICLR stock.
ICON Public Limited Company's current P/E ratio is 13.0x. The historical average is 24.3x. This places it at the 22th percentile of its historical range.
ICON Public Limited Company's current EV/EBITDA is 7.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.1x.
ICON Public Limited Company's return on equity (ROE) is 8.4%. The historical average is 14.6%.
Based on historical data, ICON Public Limited Company is trading at a P/E of 13.0x. This is at the 22th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
ICON Public Limited Company has 29.4% gross margin and 13.3% operating margin. Operating margin between 10-20% is typical for established companies.
ICON Public Limited Company's Debt/EBITDA ratio is 2.3x, indicating moderate leverage. A ratio between 2-4x is manageable but warrants monitoring.